As the number of coronavirus cases continues to rise in the U.S., Johnson & Johnson's chief scientific officer Dr. Paul Stoffels told Cheddar the company has an accelerated plan to create a vaccine.
"At the moment, we predict that we can get north of one billion vaccine dosages in the course of 2021 and even much more afterward," he said.
The company is currently running clinical trials on animals and expects to move to human testing in late July. Stoffels describes the project as a "massive amount of parallel work" that was jumpstarted by a federal investment of $456 million.
Typically, developing a vaccine calls for one to three years of successful testing, but Johnson & Johnson expects to have an approved vaccine by early 2021. One challenge the company will face is locating a pocket of study subjects — between 30,000 and 100,000 people — that have potentially been exposed. The large study size is key for the pharmaceutical giant to meet its self-imposed timeline.
"The higher the transmission rate, the faster we can see the endpoint and we can prove efficacy," Stoffels told Cheddar.
The pharmaceutical giant's confidence in distributing the vaccine by early next year also lies in cell line technology, which has the capacity to create a massive number of doses.
"In a thousand-liter vessel, we can produce more than 150 million vaccines a year," he said.
Stoffels also keyed in on the need for urgency and additional preventative steps the world should take in light of the disease still sweeping the globe.
"Nobody expected such a pandemic happening," he said. "We have learned that we have to have much more public health measures in the world."
Oracle soars as it cashes in on the AI boom, Plus: Starbucks shares continue to fall under its new CEO, and does anybody actually want a new iPhone Air?
Swedish buy now, pay later company Klarna is making its highly anticipated public debut on the New York Stock Exchange Wednesday, the latest in a run of high-profile initial public offerings this year. The offering priced at $40 Tuesday, above the forecasted range of $35 to $37 a share, valuing the company at more than $15 billion. The valuation easily makes Klarna one of the biggest IPOs so far in 2025, which has been one of the busier years for companies going public. Other popular IPOs so far this year include the design software company Figma and Circle Internet Group, which issues the USDC stablecoin..
Oracle co-founder Larry Ellison wrested the title of the world’s richest man from longtime holder Elon Musk early Wednesday as stock in his software giant rocketed more than a third in a stunning few minutes of trading. That is according to wealth tracker Bloomberg. A college dropout, the 81-year-old Ellison is now worth $393 billion, Bloomberg says, several billion more than Musk, who had been the world’s richest for four years. The switch in the ranking came after a blockbuster earnings report from Oracle. Forbes still has Musk as the richest, however, valuing his private businesses much higher.
Aurimas Sabulis, CEO of Dextall, unveils how AI‑driven prefabricated façades slash design time by 80%, labor by 87%, and accelerate affordable housing delivery.
Online broker Robinhood Markets will join the S&P 500 index Online broker Robinhood Markets will join the S&P 500 index as its stock rides higher on a cryptocurrency wave.
